Quarterly Results

  • Company Name :
Concord Biotech Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 543960
  • NSE Symbol:
  • CONCORDBIO
  • P/E(TTM):
  • 47.87
  • ISIN Demat:
  • INE338H01029
  • Div & Yield%:
  • 0.54
  • EPS(TTM):
  • 34.15
  • Book Value(₹):
  • 173.27
  • Market Cap(₹Cr.):
  • 17,103.70
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars June 2025 ( Cr)March 2025 ( Cr)December 2024 ( Cr)
Gross Sales 203.99 429.88 244.22
Excise Duty 0.00 0.00 0.00
Net Sales 203.99 429.88 244.22
Other Operating Income 0.00 0.00 0.00
Other Income 13.68 9.38 14.73
Total Income 217.67 439.27 258.95
Total Expenditure 142.59 239.46 146.27
PBIDT 75.07 199.81 112.68
Interest 0.06 0.10 0.10
PBDT 75.02 199.71 112.58
Depreciation 17.78 14.62 13.26
Tax 14.08 41.82 23.69
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.60 1.34 1.54
Reported Profit After Tax 42.57 141.94 74.09
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 42.57 141.94 74.09
EPS (Unit Curr.) 4.07 13.57 7.08
EPS (Adj) (Unit Curr.) 4.07 13.57 7.08
Calculated EPS (Unit Curr.) 4.07 13.57 7.08
Calculated EPS (Adj) (Unit Curr.) 4.07 13.57 7.08
Calculated EPS (Ann.) (Unit Curr.) 16.27 54.27 28.33
Calculated EPS (Adj) (Ann.) (Unit Curr.) 16.27 54.27 28.33
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 10.46 10.46 10.46
Reserve & Surplus 0.00 0.00 0.00
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 36.80 46.48 46.14
PBDTM(%) 36.78 46.46 46.10
PATM(%) 20.87 33.02 30.34